Latest ROE for CVRx: -180.91% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-180.91%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
CVRx (CVRX) currently reports a ROE of -180.91%. That is below the Healthcare sector average of 29.39%. Use the charts on this page to explore CVRx's ROE history and peer comparisons.
CVRx's ROE of -180.91% is lower than the Healthcare sector average of 29.39%. That is roughly 715.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but CVRx's current -180.91% should be judged against Healthcare norms (sector average: 29.39%) and against CVRX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -180.91%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.39%. From there, open related valuation or income-statement pages for CVRx, and consider following CVRX for alerts when major investors trade the stock.
CVRx is classified in the Healthcare sector. On ROE, it currently shows -180.91% versus a sector average near 29.39%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CVRX with unrelated industries.